International applause for reduced Tuberculosis cases in India
The World Health Organization (WHO) has noted big progress in India’s fight against tuberculosis (TB).
In its latest report, WHO said that TB cases in India dropped by 18%, going from 237 cases per lakh in 2015 to 195 cases per lakh in 2023.
This decline is over twice as fast as the global average, which saw only an 8% decrease.
Officials say this progress comes from India’s push to find and treat TB cases. Over 1.7 lakh Ayushman Arogya Mandirs across the country have helped make healthcare more accessible.
Last year, WHO had already adjusted its estimate of TB deaths in India. Now, the new report shows that TB deaths fell even more, from 28 per lakh to 22 per lakh — a 21% drop.
India’s TB budget has also grown a lot, from Rs 640 crores in 2015 to Rs 3,400 crores in 2022-23, mostly funded by the government.
The health ministry is also adding more than 800 portable chest X-ray machines with AI support to boost TB testing.
Right now, India has the biggest TB lab network globally, with 7,767 rapid testing centers and 87 drug testing labs across the country.
In September, the government approved a new treatment plan, called the BPaLM regimen, for tackling Multidrug-Resistant TB (MDR-TB) under its National TB Elimination Program.
This treatment is shorter and highly effective. India also reported a slight rise in new TB cases, with 19.8 lakh cases reported between January and September 2024, up from 19 lakh during the same period last year.
Image Credit: https://www.myupchar.com/, https://www.myupchar.com/en/disease/tuberculosis-tb CC BY-SA 4.0, via Wikimedia Common
You may also like
Recent Posts
- India’s food waste problem: A growing crisis at homeIndia has one of the highest numbers of undernourished people, yet millions of tonnes of food end up in the trash.
- Big boost for CG employees: Govt overhauls CGHS rateshis is the most significant change in CGHS in the last 15 years.
- US tariffs hit Indian pharma: A warning sign for exportsThe United States has imposed a 100% tariff on imported branded and patented drugs, a move that directly targets foreign manufacturers. While Indian generic drugs remain exempt for now, the policy raises serious concerns for India’s pharmaceutical industry and its future in the US market.
- India’s food waste problem: A growing crisis at home
What’s new at WeRIndia.com
News from 700+ sources
-
Armed gang attacks two men, snatches mobile phones in Peraiyur in Madurai district
-
One held for submitting fake land documents for registration
-
SpiceJet Announces New Flights Connecting Ayodhya With Delhi, Ahmedabad, Bengaluru and Hyderabad
-
Central Govt Hikes DA For Employees To 58% From July 1
-
Kruthik, Shikhar picked in Karnataka Ranji squad
-
Andhra Pradesh CPI secretary demands caste census for development of backward classes
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..
Leave a Reply